Bora Pharmaceuticals Co., Ltd. (TPE:6472)

Taiwan · Delayed Price · Currency is TWD

455.00

-6.00 (-1.30%)

At close: Mar 26, 2026

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Sales Operations Department			9.25B	5.76B	532.39M	500.32M	418.49M
Sales Operations Department Growth			60.59%	982.02%	6.41%	19.55%	15.17%
CDMO Operations Department			5.44B	4.84B	4.42B	1.31B	1.16B
CDMO Operations Department Growth			12.44%	9.43%	236.74%	13.37%	11.09%
Other Operations Department			273.38M	202.85M	85.09M	40.19M	1.79M
Other Operations Department Growth			34.77%	138.41%	111.69%	2142.91%	133.94%
Adjustments and Eliminations			-761.19M	-304.00M	-135.84M	-53.01M	-48.42M
Total			14.20B	10.49B	4.90B	1.80B	1.53B
Total Growth			35.31%	114.18%	172.28%	17.68%	11.42%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Europe			2.08B	3.13B	3.39B	214.75M	-
Europe Growth			-33.51%	-7.78%	1480.09%	-	-
United States			10.96B	6.51B	861.59M	968.95M	974.94M
United States Growth			68.17%	656.10%	-11.08%	-0.61%	8.30%
Taiwan			1.05B	850.69M	645.02M	615.87M	554.28M
Taiwan Growth			23.81%	31.88%	4.73%	11.11%	17.37%
Other			110.93M	-	-	-	-
Total			14.20B	10.49B	4.90B	1.80B	1.53B
Total Growth			35.31%	114.18%	172.28%	17.68%	11.42%

Source: S&P Global Market Intelligence.